Proteomics and drug discovery

Contributions to Nephrology

Volumn 141, Issue , 2004, Pages 308-327

  Jain, K K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745208159     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (26)

1. Jain KK: Proteomics: Technologies Markets and Companies. Basel, Jain Pharma Biotech Publications, 2003.
2. Gygi SP, Rist B, Gerber SA et al: Quantitative analysis of protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999;17:994-999.
3. Moseley MA: Current trends in differential expression proteomics: Isotopically coded tags, Trends Biotechnol 2001;19(suppl):10-16.
4. McDonald WH, Yates JR 3rd: Shotgun proteomics and biomarker discovery. Dis Markers 2002;18:99-105.
5. Ziauddin J, Sabatini DM: Microarrays of cells expressing defined cDNAs. Nature 2001;411:107-110.
6. Nattkemper TW, Ritter HJ, Schubert W: A neural classifier enabling high-throughput topological analysis of lymphocytes in tissue sections. IEEE Trans Inf Technol Biomed 2001;5:138-149.
7. Lach-Trifilieff E, McKay RA, Monia BP et al: In vitro and in vivo inhibition of interleukin (IL)-S-mediated eosinopoiesis by murine IL-5Ra antisense oligonucleotide. Am J Respir Cell Mol Biol 2001;24:116-122.
8. Rubenwolf S, Niewohner, J Meyer E et al: Functional proteomics using chromophore-assisted laser inactivation. Proteomics 2002;2:241-246.
9. Jain KK: Application of laser capture microdissection to proteomics. Methods Enzymol 2002;356:157-167.
10. Resing KA: Analysis of signaling pathways using functional proteomics. Ann NY Acad Sci 2002;971:608-614.
11. Salomon AR, Ficarro SB, Brill LM et al: Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci USA 2003;100:443-448.
12. Ficarro, SB, McCleland ML Stukenberg PT et al: Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 2002;20:301-305.
13. Sastry SK, Lyons PD, Schaller MD, Burridge K: PTP-PEST controls motility through regulation of Rac 1. J Cell Sci 2002;115:4305-4316.
14. Clough J: CDK inhibitor shows promise for inflammatory kidney disease. Drug Discov Today 2002;7:789-790.
15. Nicholson JK, Connelly J, Lindon JC, Holmes E: Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002;1:153-161.
16. Raamsdonk LM, Teusink B, Broadhurst D et al: A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 2001;19:45-50.
17. IdekerT, Thorsson V, Ranish JA et al: Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 2001;292:929-934.
18. Hayden PS, Iyengar SK, Schelling JR, Sedor JR. Kidney disease, genotype and the pathogenesis of vasculopathy. Curr Opin Nephrol Hypertens 2003;12:71-78.
19. Katsuma S, Shiojima S, Hirasawa A et al: Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 2002;296:544-552.
20. Arthur JM, Thongboonkerd V, Scherzer JA, Cai J, Pierce WM, Klein JB: Differential expression of proteins in renal cortex and medulla: A proteomic approach. Kidney Int 2002;62:1314-1321.
21. Knepper MA: Proteomics and the kidney. J Am Soc Nephrol 2002;13:1398-1408.
22. Balabanov S, Zimmermann U, Protzel C et al: Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. Eur J Biochem 2001;268:5977-5980.
23. Von Eggeling F, Junker K, Fiedle W et al: Mass spectrometry meets chip technology: A new proteomic tool in cancer research? Electrophoresis 2001;22:2898-2902.
24. Lichtenfels R, Kellner R, Bukur J et al: Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics 2002;2:561-570.
25. Klade CS, Voss T, Krystek E et al: Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 2001;1:890-898.
26. Michael A, Pandha HS: Renal-cell carcinoma: Tumour markers, T-cell epitopes and potential for new therapies. Lancet Oncol 2003;4:215-223.